Loss of bHLH transcription factor Id4 modulates androgen receptor activity in prostate cancer progression

被引：0
|
作者：
Carey, Jason P. [1 ]
Chaudhary, Jaideep [1 ]
机构：
[1] Clark Atlanta Univ, Atlanta, GA 30314 USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-3927
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3927
引用
收藏
页数：1
相关论文
共 50 条
  • [1] bHLH transcription factor Id4 plays a regulatory role in cell cycle control, apoptosis, and senescence in androgen-insensitive prostate cancer
    Jason, Carey P.
    Chaudhary, Jaideep
    Evans, Ashley
    CANCER RESEARCH, 2010, 70
  • [2] Id4 and FKBP52 interaction regulates androgen receptor activity in normal prostate and prostate cancer
    Joshi, Jugal B.
    CANCER RESEARCH, 2014, 74 (19)
  • [3] Inducible overexpression of bHLH transcriptional regulator Id4 abrogates tumorigenicity of prostate cancer xenografts
    Patel, Divya
    Morton, Derrick J.
    Korang-Yeboah, Maxwell
    Gorantla, Yamini
    Bhosle, Sushma
    Nagappan, Perri
    Bowen, Nathen
    Chaudhary, Jaideep
    CANCER RESEARCH, 2015, 75
  • [4] Transcription factor, Id4, induced cellular reprogramming of cancer cells using an advanced prostate cancer cell model
    Carey, J. P.
    Chaudhary, J. C.
    Asirvatham, A. J.
    Evans, A.
    EJC SUPPLEMENTS, 2010, 8 (07): : 185 - 186
  • [5] LOSS OF EPITHELIAL ANDROGEN RECEPTOR PROMOTES PROSTATE CANCER PROGRESSION
    Niu, Yuanjie
    Yeh, Shuyuan
    Chang, Chawnshang
    JOURNAL OF UROLOGY, 2009, 181 (04): : 260 - 260
  • [6] Role of the transcription factor Id4 in the developing mammary gland
    Best, Sarah A.
    Fu, NaiYang
    Vaillant, Francois
    Lindeman, Geoff J.
    Visvader, Jane E.
    MOLECULAR CANCER RESEARCH, 2013, 11
  • [7] CtBP2 Modulates the Androgen Receptor to Promote Prostate Cancer Progression
    Takayama, Ken-ichi
    Suzuki, Takashi
    Fujimura, Tetsuya
    Urano, Tomohiko
    Takahashi, Satoru
    Homma, Yukio
    Inoue, Satoshi
    CANCER RESEARCH, 2014, 74 (22) : 6542 - 6553
  • [8] ID4 is frequently downregulated and partially hypermethylated in prostate cancer
    Anna Vinarskaja
    Wolfgang Goering
    Marc Ingenwerth
    Wolfgang A. Schulz
    World Journal of Urology, 2012, 30 : 319 - 325
  • [9] ID4 is frequently downregulated and partially hypermethylated in prostate cancer
    Vinarskaja, Anna
    Goering, Wolfgang
    Ingenwerth, Marc
    Schulz, Wolfgang A.
    WORLD JOURNAL OF UROLOGY, 2012, 30 (03) : 319 - 325
  • [10] Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer
    Jason PW Carey
    Ananthi J Asirvatham
    Oliver Galm
    Tandeih A Ghogomu
    Jaideep Chaudhary
    BMC Cancer, 9
12345